Novel amination process

Details for Australian Patent Application No. 2005223729 (hide)

Owner AstraZeneca AB

Inventors O'Kearney-McMullan, Anne; Norton, Alison; Robinson, Graham; Dekhane, Mouloud

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005223729

PCT Pub. Number WO2005/090318

Priority 0400759-7 23.03.04 SE

Filing date 22 March 2005

Wipo publication date 29 September 2005

International Classifications

C07D 241/02 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090318 Priority application(s): WO2005/090318

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223736-Prodrugs of piperazine and substituted piperidine antiviral agents

2005223728-Azabicyclooctan-3-one derivatives and use thereof